Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanisms of action of antiseizure drugs.

Literature DB >> 22939059

Mechanisms of action of antiseizure drugs.

Roger J Porter¹, Ashish Dhir, Robert L Macdonald, Michael A Rogawski.

Abstract

Mesh：

Substances：
Anticonvulsants

Year: 2012 PMID： 22939059 DOI： 10.1016/B978-0-444-52899-5.00021-6

Source DB: PubMed Journal: Handb Clin Neurol ISSN： 0072-9752

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

1. Pro- and Anticonvulsant Effects of the Ant Dinoponera quadriceps (Kempf) Venom in Mice.

Authors: D A M F Nôga; F C Cagni; J R Santos; D Silva; D L O Azevedo; A Araújo; R H Silva; A M Ribeiro
Journal: Neotrop Entomol Date: 2015-06-05 Impact factor: 1.434

2. The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant.

Authors: Nichole Coleman; Hai M Nguyen; Zhengyu Cao; Brandon M Brown; David Paul Jenkins; Dorota Zolkowska; Yi-Je Chen; Brian S Tanaka; Alan L Goldin; Michael A Rogawski; Isaac N Pessah; Heike Wulff
Journal: Neurotherapeutics Date: 2015-01 Impact factor: 7.620

Review 3. Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists.

Authors: Rasmus M Christensen; Christian R Juhl; Signe S Torekov
Journal: Drug Saf Date: 2019-08 Impact factor: 5.606

Review 4. Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors: Martin Holtkamp
Journal: Drugs Date: 2018-03 Impact factor: 9.546

Review 5. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.

Authors: Rafal M Kaminski; Michael A Rogawski; Henrik Klitgaard
Journal: Neurotherapeutics Date: 2014-04 Impact factor: 7.620

Mechanisms of action of antiseizure drugs.

1. Pro- and Anticonvulsant Effects of the Ant Dinoponera quadriceps (Kempf) Venom in Mice.

2. The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant.

Review 3. Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists.

Review 4. Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Review 5. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.

6. Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats.

Review 7. Glutamate and Its Receptors as Therapeutic Targets for Migraine.

8. Inhibition of TRPC3 channels by a novel pyrazole compound confers antiseizure effects.

Review 9. Medications for alcohol use disorders: An overview.

Review 10. Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?